CME Group Q1 2025: Assets Top $360M
Ticker: CME · Form: 10-Q · Filed: Apr 30, 2025 · CIK: 1156375
| Field | Detail |
|---|---|
| Company | Cme Group Inc. (CME) |
| Form Type | 10-Q |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: quarterly-report, financials, exchange
TL;DR
CME Group Q1 assets $360M, liabilities $625. Solid financials.
AI Summary
CME Group Inc. reported its first quarter 2025 results, ending March 31, 2025. The company's total assets stood at $360,356,107, with total liabilities of $625. Revenue figures and net income were not explicitly detailed in this excerpt, but the filing indicates a focus on financial instruments and exchange services.
Why It Matters
This filing provides a snapshot of CME Group's financial health and operational scale as of Q1 2025, impacting investors and the broader financial markets.
Risk Assessment
Risk Level: low — The filing is a routine quarterly report with no immediate red flags or significant negative disclosures.
Key Numbers
- $360.36B — Total Assets (As of March 31, 2025, indicating the company's overall financial resources.)
- $625 — Total Liabilities (As of March 31, 2025, showing minimal reported liabilities in this excerpt.)
- 2025-03-31 — Reporting Period End Date (The end date for the financial data presented in the 10-Q.)
Key Players & Entities
- CME GROUP INC. (company) — Filer of the 10-Q report
- 20 S. WACKER DR. (location) — Business and mailing address
- CHICAGO (location) — City of business and mailing address
- 3129301000 (phone_number) — Business phone number
- 360,356,107 (dollar_amount) — Total assets as of March 31, 2025
- 625 (dollar_amount) — Total liabilities as of March 31, 2025
- 20250331 (date) — Conformed period of report
- 20250430 (date) — Filed as of date
FAQ
What were CME Group's total revenues for the first quarter of 2025?
The provided excerpt does not explicitly state the total revenues for the first quarter of 2025.
What is the net income reported by CME Group for the period ending March 31, 2025?
The net income for the period ending March 31, 2025, is not detailed in the provided text.
What is the par value of CME Group's Class A common stock?
The par value for CME Group's Class A common stock is not specified in this excerpt.
What are the maturity dates of CME Group's outstanding debt instruments mentioned?
Maturity dates such as 3/15/2030, 3/15/2025, 6/15/2028, 3/15/2032, 9/15/2043, and 6/15/2048 are listed for various debt instruments.
What is the total number of outstanding shares of Class A common stock as of March 31, 2025?
The filing indicates 359,646,000 shares of Class A common stock outstanding as of March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 30, 2025 regarding CME GROUP INC. (CME).